EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Application of Chromosomal Karyotype Analysis Combined With Chromosomal Microarray Analysis in the Amniotic Fluid of Advanced Maternal Age

Caihong Liu, Yan Lu, Baohui Zhang, Liucui Yu, Jing He, Yan Ji iD

Journal of Clinical Laboratory Analysis · 2025

DOI: 10.1002/jcla.70020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Caihong Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prenatal Diagnostic Centre, Huizhou Central People's Hospital, Huizhou, Guangdong, China. Hauptthemen laut MEDLINE: Amniotic Fluid, Maternal Age, Karyotyping, Microarray Analysis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the application and value of chromosomal karyotype analysis combined with Chromosomal Microarray Analysis (CMA) in the amniotic fluid of advanced maternal age.

Methods

A total of 817 advanced maternal age (AMA) who underwent amniocentesis at the Prenatal Diagnosis Center of Huizhou Central People's Hospital between January 2018 and July 2024 were enrolled in this study. The women were grouped based on different age ranges and prenatal diagnosis factors. These groups were used to compare the detection rates and differences between chromosomal karyotype analysis and CMA.

Result

The overall chromosomal abnormality rates detected by karyotype analysis in the 35–39 years age group and the ≥ 40 years age group were 8.81% and 13.79%, respectively, with a statistically significant difference ( p < 0.05). For CMA, the overall abnormality rates in the same age groups were 10.79% and 15.33%, respectively, but the difference was not statistically significant ( p > 0.05). The non‐solely advanced‐age group (those with additional factors beyond just advanced age) had higher overall chromosomal abnormality rates, aneuploidy rates, structural abnormality rates, and mosaicism rates compared to the solely advanced‐age group, with statistically significant differences ( p < 0.05). Additionally, the non‐solely advanced‐age group had a higher overall abnormality rate detected by CMA compared to the solely advanced‐age group, with a statistically significant difference ( p < 0.05). However, there were no statistically significant differences between the two groups in terms of the detection of pathogenic, likely pathogenic, and variants of uncertain significance ( p > 0.05). In this study, a total of 68 cases were identified where the results of karyotype analysis and CMA were inconsistent.

Conclusion

The overall abnormal rate of chromosomal karyotype analysis increases with maternal age, while the overall abnormal rate of CMA shows no significant correlation with maternal age. The abnormal rates are significantly higher in AMA with additional factors. The combination of chromosomal karyotype analysis and CMA can validate and complement each other, thereby improving the detection rates of chromosomal abnormalities in amniotic fluid samples of AMA. This provides a diagnostic basis for subsequent pregnancy choices, which effectively reduces the birth of fetuses with chromosomal abnormalities and enhances population quality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amniotic FluidMaternal AgeKaryotypingMicroarray AnalysisChromosome DisordersHumansFemaleAdultPregnancyChromosome AberrationsAmniocentesisPrenatal DiagnosisAdvanced Maternal Age

Stichwörter der Autor:innen

advanced matemal ageamniotic fluidchromosomal microarray analysischromosome karyotype analysis

Autor:innen und Institutionen

  • Department of Prenatal Diagnostic Centre, Huizhou Central People's Hospital, Huizhou, Guangdong, China.

ORCID-Profile: Yan Ji

Zitieren

APA

Liu, C., Lu, Y., Zhang, B., Yu, L., He, J., & Ji, Y. (2025). Application of Chromosomal Karyotype Analysis Combined With Chromosomal Microarray Analysis in the Amniotic Fluid of Advanced Maternal Age. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70020

Vancouver

Liu C, Lu Y, Zhang B, Yu L, He J, Ji Y. Application of Chromosomal Karyotype Analysis Combined With Chromosomal Microarray Analysis in the Amniotic Fluid of Advanced Maternal Age. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.70020

BibTeX
@article{Liu2025,
  author = {Liu, Caihong and Lu, Yan and Zhang, Baohui and Yu, Liucui and He, Jing and Ji, Yan},
  title = {Application of Chromosomal Karyotype Analysis Combined With Chromosomal Microarray Analysis in the Amniotic Fluid of Advanced Maternal Age},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2025},
  doi = {10.1002/jcla.70020}
}
Kostenlos starten →